Semaglutide
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
Novo Nordisk · Phase 3 · Completed · Enrollment 408
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| TQF3510 | n/r | n/r | n/r | n/r | n/r |
| Wegovy® | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.